These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 756020

  • 1. Patterns of response to levodopa in Parkinson's disease.
    Vajda FJ, Donnan GA, Bladin PF.
    Clin Exp Neurol; 1978; 15():299-306. PubMed ID: 756020
    [Abstract] [Full Text] [Related]

  • 2. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV, Sternić NM, Filipović SR, Vojvodić NM, Kostić VS.
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [Abstract] [Full Text] [Related]

  • 3. The impact of treatment with levodopa on Parkinson's disease.
    Shaw KM, Lees AJ, Stern GM.
    Q J Med; 1980; 49(195):283-93. PubMed ID: 7465763
    [Abstract] [Full Text] [Related]

  • 4. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
    Jost WH, Klasser M, Reichmann H.
    Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
    [Abstract] [Full Text] [Related]

  • 5. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS, Kirby L, Kumar D, Cullen EI, Pratt RD, Hahne WA.
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [Abstract] [Full Text] [Related]

  • 6. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa.
    Aarli JA, Gilhus NE.
    Neurology; 1989 Nov; 39(11 Suppl 2):82-5; discussion 95. PubMed ID: 2586767
    [Abstract] [Full Text] [Related]

  • 7. The effects of early selegiline therapy on long-term levodopa treatment and parkinsonian disability: an interim analysis of a Norwegian--Danish 5-year study. Norwegian-Danish Study Group.
    Larsen JP, Boas J.
    Mov Disord; 1997 Mar; 12(2):175-82. PubMed ID: 9087975
    [Abstract] [Full Text] [Related]

  • 8. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort InvestigatorsDepartment of Neurology, University of Rochester, 1351 Mt Hope Ave, Ste 220, Rochester, NY 14620, USA. kevin.biglan@ctcc.rochester.edu.
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [Abstract] [Full Text] [Related]

  • 9. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study.
    Im JH, Ha JH, Cho IS, Lee MC.
    J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999
    [Abstract] [Full Text] [Related]

  • 10. The Sydney multicentre study of Parkinson's disease. The first 18 months.
    Hely MA, Morris JG, Rail D, O'Sullivan DJ, Williamson PM, Genge S, Reid WG, Broe GA.
    Med J Aust; 1987 Feb 16; 146(4):195-8. PubMed ID: 3553878
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr 16; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 16. The effects of combining carbidopa with levodopa for Parkinson's disease.
    Martin WE, Tolosa ES, Loewenson RB, Lee MC, Resch JA, Baker AB.
    Geriatrics; 1975 Dec 16; 30(12):39-44. PubMed ID: 1104406
    [No Abstract] [Full Text] [Related]

  • 17. Sustained low-dose levodopa therapy in Parkinson's disease: a 3-year follow-up.
    Lees AJ, Stern GM.
    Adv Neurol; 1983 Dec 16; 37():9-15. PubMed ID: 6858781
    [Abstract] [Full Text] [Related]

  • 18. Young onset Parkinson's disease.
    Quinn N, Critchley P, Marsden CD.
    Mov Disord; 1987 Dec 16; 2(2):73-91. PubMed ID: 3504266
    [Abstract] [Full Text] [Related]

  • 19. Longitudinal study of the motor response to levodopa in Parkinson's disease.
    Clissold BG, McColl CD, Reardon KR, Shiff M, Kempster PA.
    Mov Disord; 2006 Dec 16; 21(12):2116-21. PubMed ID: 17029259
    [Abstract] [Full Text] [Related]

  • 20. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A, Parkinson Study Group.
    Arch Neurol; 2004 Jul 16; 61(7):1044-53. PubMed ID: 15262734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.